Postimplementation program evaluation data for 2 Lighthouse Trust pilot sites in Lilongwe, Malawi, February 2015 to June 2016.

<p>Postimplementation program evaluation data for 2 Lighthouse Trust pilot sites in Lilongwe, Malawi, February 2015 to June 2016.</p

Example core process and outcome indicators for an integrated hypertension/human immunodeficiency virus (HIV) clinical management program examined at 6-month intervals.

<p>Example core process and outcome indicators for an integrated hypertension/human immunodeficiency virus (HIV) clinical management program examined at 6-month intervals.</p

Recommended elements for successful hypertension and human immunodeficiency virus (HIV) management integration.

<p>Recommended elements for successful hypertension and human immunodeficiency virus (HIV) management integration.</p

Demographic characteristics and HIV risk behaviors of 2268 clients whose finger-stick whole blood and oral fluid specimens were tested with the OraQuick Advance rapid HIV test, by state—incidence study, February 2005 through May 2005.

<p>A/PI/AI/AN/Other, Asian/Pacific Islander/American Indian/Alaska Native/Other; IDU, injection drug user; MSM, men who have sex with men; STD, sexually transmitted diseases.</p>a<p>Risk behaviors are not mutually exclusive.</p

OraQuick Advance rapid HIV antibody test results for 2268 clients tested with oral fluid, Incidence Study, February 2005 to June 2005.

a<p>Test line intensity of test device compared to test line intensity of low-positive external control.</p

Figure 1

<p>Epidemic curve of false-positive OraQuick rapid HIV antibody test results, oral fluid, by Month and Lot, University of Minnesota study, July 2002 through August 2004.</p